Decoding the molecular enigma behind asbestos and fibrous nanomaterial-induced carcinogenesis

  • 0Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

|

|

Summary

This summary is machine-generated.

Asbestos fibers cause mesothelioma by accumulating iron, leading to DNA damage and tumor suppressor gene deletion in mesothelial cells. Reducing local iron may prevent this cancer.

Area Of Science

  • Oncology
  • Environmental Health
  • Molecular Biology

Background

  • Asbestos exposure has been linked to mesothelioma since the 1960s.
  • Asbestos is classified as a Group 1 carcinogen by the International Agency for Research on Cancer.
  • The precise molecular mechanisms of asbestos-induced mesothelial carcinogenesis remain incompletely understood.

Purpose Of The Study

  • To elucidate the molecular mechanisms underlying asbestos-induced mesothelial carcinogenesis.
  • To explain why mesothelial cells are the primary target for asbestos-related cancer.
  • To review recent discoveries that resolve scientific enigmas in this field.

Main Methods

  • Review of recent findings from laboratory research and external studies.
  • Focus on the journey of asbestos fibers through lung tissue.
  • Analysis of the interaction between asbestos fibers, iron, and mesothelial cells.

Main Results

  • Asbestos fibers travel to the parietal mesothelium over 30-40 years, accumulating iron by binding to hemoglobin and histones.
  • Mesothelial cells phagocytose iron-coated asbestos fibers, leading to oxidative DNA damage.
  • Homozygous deletion of the p16INK4a tumor suppressor gene, a result of iron-induced carcinogenesis, is observed.
  • Exosome-mediated iron transfer from macrophages to mesothelial cells contributes to carcinogenesis.
  • Similar mechanisms are observed with multiwalled carbon nanotubes.

Conclusions

  • Fiber dimensions, biopersistence, and affinity for iron/histones are critical for mesothelial cell carcinogenicity.
  • Local iron reduction is proposed as a potential preventative strategy against mesothelial carcinogenesis.

Related Concept Videos

Mutagenicity and Carcinogenicity 01:25

1.2K

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Skin Cancer 01:30

3.1K

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

The Tumor Microenvironment 02:17

6.5K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Adaptive Mechanisms in Cancer Cells 02:53

5.7K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...